These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3861199)

  • 1. Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders.
    Stahl SM; Thornton JE; Simpson ML; Berger PA; Napoliello MJ
    Biol Psychiatry; 1985 Aug; 20(8):888-93. PubMed ID: 3861199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.
    Gaio JM; Pollak P; Hommel M; Perret J
    J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1674-8. PubMed ID: 3437301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
    Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA
    Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gamma-vinyl GABA in tardive dyskinesia.
    Korsgaard S; Casey DE; Gerlach J
    Psychiatry Res; 1983 Apr; 8(4):261-9. PubMed ID: 6136054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA agonist treatment improves tardive dyskinesia.
    Tamminga CA; Thaker GK; Ferraro TN; Hare TA
    Lancet; 1983 Jul; 2(8341):97-8. PubMed ID: 6134975
    [No Abstract]   [Full Text] [Related]  

  • 6. gamma-Acetylenic GABA in tardive dyskinesia.
    Casey DE; Gerlach J; Magelund G; Christensen TR
    Arch Gen Psychiatry; 1980 Dec; 37(12):1376-9. PubMed ID: 6108751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA system: clinical research and treatment of tardive dyskinesia.
    Thaker GK; Hare TA; Tamminga CA
    Mod Probl Pharmacopsychiatry; 1983; 21():155-67. PubMed ID: 6419061
    [No Abstract]   [Full Text] [Related]  

  • 8. GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias.
    Andersson U; Häggström JE
    Psychopharmacology (Berl); 1988; 94(3):298-301. PubMed ID: 2895937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.
    Grant SM; Heel RC
    Drugs; 1991 Jun; 41(6):889-926. PubMed ID: 1715266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Turjanski N; Lees AJ
    J Neurol Neurosurg Psychiatry; 1992 May; 55(5):413. PubMed ID: 1602321
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: a new gamma-aminobutyric acid agonist.
    Korsgaard S; Casey DE; Gerlach J; Hetmar O; Kaldan B; Mikkelsen LB
    Arch Gen Psychiatry; 1982 Sep; 39(9):1017-21. PubMed ID: 6126170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
    Lambert PA; Cantiniaux P; Chabannes JP; Tell GP; Schechter PJ; Koch-Weser J
    Encephale; 1982; 8(3):371-6. PubMed ID: 6137357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy.
    Loiseau P; Hardenberg JP; Pestre M; Guyot M; Schechter PJ; Tell GP
    Epilepsia; 1986; 27(2):115-20. PubMed ID: 3514204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid GABA and seizure control with vigabatrin.
    Riekkinen PJ; Ylinen A; Halonen T; Sivenius J; Pitkanen A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazepam in tardive dyskinesia.
    Weber SS; Dufresne RL; Becker RE; Mastrati P
    Drug Intell Clin Pharm; 1983; 17(7-8):523-7. PubMed ID: 6135591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of total gamma-aminobutyric acid (GABA), free GABA and homocarnosine in cerebrospinal fluid of epileptic patients before and during gamma-vinyl-GABA (vigabatrin) treatment.
    Pitkänen A; Matilainen R; Ruutiainen T; Riekkinen P
    J Neurol Sci; 1988 Dec; 88(1-3):83-93. PubMed ID: 3225631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study on the treatment of dyskinesia by L-stepholidine].
    Le W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Dec; 22(6):335-7, 381-2. PubMed ID: 2700694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gamma-vinyl-GABA on the human electroencephalogram.
    Hammond EJ; Wilder BJ
    Neuropharmacology; 1985 Oct; 24(10):975-84. PubMed ID: 2999635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-vinyl GABA.
    Hammond EJ; Wilder BJ
    Gen Pharmacol; 1985; 16(5):441-7. PubMed ID: 2932363
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental studies and controlled clinical testing of valproate and vigabatrin.
    Gram L
    Acta Neurol Scand; 1988 Oct; 78(4):241-70. PubMed ID: 3146860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.